{"log_id": 1796842131380318593, "direction": 0, "words_result_num": 74, "words_result": [{"probability": {"variance": 0.001369, "average": 0.983253, "min": 0.850895}, "location": {"width": 300, "top": 150, "height": 23, "left": 733}, "words": "注射用伏立康唑说明书第8页/共页"}, {"probability": {"variance": 0.003969, "average": 0.970592, "min": 0.783871}, "location": {"width": 152, "top": 171, "height": 20, "left": 229}, "words": "见【注意事项】的警告"}, {"probability": {"variance": 5e-06, "average": 0.998069, "min": 0.993653}, "location": {"width": 106, "top": 204, "height": 19, "left": 260}, "words": "机器能力的影响"}, {"probability": {"variance": 0.003118, "average": 0.979991, "min": 0.650705}, "location": {"width": 626, "top": 233, "height": 25, "left": 197}, "words": "本品可能会引起一过性的、可逆性的视觉改变,包括视力模糊、视觉改变、视觉增强和或畏光"}, {"probability": {"variance": 5e-06, "average": 0.998152, "min": 0.99305}, "location": {"width": 122, "top": 237, "height": 19, "left": 883}, "words": "现上述症状时必须"}, {"probability": {"variance": 0.000569, "average": 0.983799, "min": 0.899828}, "location": {"width": 256, "top": 255, "height": 18, "left": 182}, "words": "事有危险的工作,例如驾驶或操作机器"}, {"probability": {"variance": 3e-06, "average": 0.998465, "min": 0.99541}, "location": {"width": 59, "top": 286, "height": 18, "left": 167}, "words": "专用溶媒"}, {"probability": {"variance": 0.003888, "average": 0.972485, "min": 0.645665}, "location": {"width": 827, "top": 319, "height": 21, "left": 195}, "words": "本品专用溶媒成份为丙二醇和乙醇的灭菌混合溶液(含丙二醇2ml,乙醇3ml),本品与其它药物联合使用时应考虑溶媒成价时药"}, {"probability": {"variance": 1e-06, "average": 0.994688, "min": 0.993944}, "location": {"width": 47, "top": 340, "height": 18, "left": 174}, "words": "的影响"}, {"probability": {"variance": 0.000121, "average": 0.991707, "min": 0.966767}, "location": {"width": 266, "top": 373, "height": 21, "left": 201}, "words": "品专用溶媒含乙醇,对乙醇过敏者慎用"}, {"probability": {"variance": 0.000157, "average": 0.990996, "min": 0.963195}, "location": {"width": 167, "top": 406, "height": 17, "left": 170}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 1e-06, "average": 0.998624, "min": 0.997463}, "location": {"width": 31, "top": 438, "height": 18, "left": 161}, "words": "孕妇"}, {"probability": {"variance": 0.012366, "average": 0.968031, "min": 0.499944}, "location": {"width": 292, "top": 469, "height": 22, "left": 188}, "words": "日前伏立康唑在孕妇中的应用尚无足够资料"}, {"probability": {"variance": 0.003288, "average": 0.985128, "min": 0.695144}, "location": {"width": 599, "top": 503, "height": 20, "left": 189}, "words": "动物实验显示本品有生殖毒性(参见临床前安全性资料),但对人体的潜在危险性尚未确定"}, {"probability": {"variance": 0.002746, "average": 0.979939, "min": 0.761921}, "location": {"width": 469, "top": 534, "height": 21, "left": 187}, "words": "伏立康唑不宜用于孕妇,除非对母亲的益处显著大于对胎儿的潜在毒性"}, {"probability": {"variance": 8e-06, "average": 0.99557, "min": 0.992944}, "location": {"width": 61, "top": 572, "height": 17, "left": 171}, "words": "龄期妇女"}, {"probability": {"variance": 0.002344, "average": 0.981578, "min": 0.797644}, "location": {"width": 352, "top": 606, "height": 22, "left": 197}, "words": "育龄期妇女应用伏立康唑期间需采取有效的避孕措施"}, {"probability": {"variance": 2e-06, "average": 0.998544, "min": 0.997116}, "location": {"width": 62, "top": 643, "height": 18, "left": 167}, "words": "乳期妇女"}, {"probability": {"variance": 4.1e-05, "average": 0.996682, "min": 0.977928}, "location": {"width": 156, "top": 678, "height": 21, "left": 259}, "words": "唑在乳汁中分泌的资料"}, {"probability": {"variance": 0, "average": 0.998951, "min": 0.998951}, "location": {"width": 15, "top": 681, "height": 17, "left": 744}, "words": "伏"}, {"probability": {"variance": 0.000938, "average": 0.977349, "min": 0.91706}, "location": {"width": 74, "top": 710, "height": 19, "left": 164}, "words": "儿童用药】"}, {"probability": {"variance": 0.001996, "average": 0.980451, "min": 0.810672}, "location": {"width": 361, "top": 747, "height": 20, "left": 181}, "words": "伏立康唑在12岁以下儿童的安全性和有效性尚未建立"}, {"probability": {"variance": 0.013326, "average": 0.9598, "min": 0.384489}, "location": {"width": 481, "top": 781, "height": 26, "left": 180}, "words": "在治疗性研究中共入选年龄为1218岁的侵袭性曲霉病患者22例,分别给"}, {"probability": {"variance": 0.073638, "average": 0.725062, "min": 0.453698}, "location": {"width": 35, "top": 784, "height": 18, "left": 719}, "words": "E的"}, {"probability": {"variance": 1e-05, "average": 0.997666, "min": 0.991277}, "location": {"width": 137, "top": 783, "height": 19, "left": 838}, "words": "每12小时1次每次"}, {"probability": {"variance": 0.009139, "average": 0.928549, "min": 0.793392}, "location": {"width": 32, "top": 803, "height": 18, "left": 150}, "words": "12例"}, {"probability": {"variance": 0.019841, "average": 0.932946, "min": 0.6183}, "location": {"width": 88, "top": 805, "height": 16, "left": 237}, "words": "患者治疗有效"}, {"probability": {"variance": 0.002776, "average": 0.985975, "min": 0.711597}, "location": {"width": 456, "top": 838, "height": 20, "left": 178}, "words": "在治疗研究中,对伏立唑在青少年中的药代动力学特性研究的很少"}, {"probability": {"variance": 0.038856, "average": 0.782017, "min": 0.393135}, "location": {"width": 330, "top": 812, "height": 44, "left": 665}, "words": "受理号CAB·1YOy"}, {"probability": {"variance": 2.1e-05, "average": 0.996384, "min": 0.989968}, "location": {"width": 62, "top": 870, "height": 17, "left": 175}, "words": "年用药"}, {"probability": {"variance": 0.008071, "average": 0.946351, "min": 0.718005}, "location": {"width": 134, "top": 877, "height": 30, "left": 800}, "words": "009-12-16"}, {"probability": {"variance": 0.001796, "average": 0.983691, "min": 0.768582}, "location": {"width": 457, "top": 904, "height": 22, "left": 175}, "words": "在多剂量给药的治疗研究中,≥65岁的患者占92%,≥75岁的患者"}, {"probability": {"variance": 0.010873, "average": 0.956493, "min": 0.662294}, "location": {"width": 135, "top": 907, "height": 20, "left": 869}, "words": "的研究显示,老年男"}, {"probability": {"variance": 0.004249, "average": 0.962794, "min": 0.793378}, "location": {"width": 212, "top": 924, "height": 21, "left": 152}, "words": "的总暴露量(AUC)和血药峰浓度"}, {"probability": {"variance": 0.011318, "average": 0.965193, "min": 0.597314}, "location": {"width": 186, "top": 924, "height": 20, "left": 426}, "words": "较年轻男性为高。对10项伏"}, {"probability": {"variance": 0.000622, "average": 0.988193, "min": 0.916053}, "location": {"width": 149, "top": 945, "height": 18, "left": 147}, "words": "果显示静脉滴注或口服"}, {"probability": {"variance": 6.7e-05, "average": 0.991722, "min": 0.983527}, "location": {"width": 30, "top": 947, "height": 15, "left": 343}, "words": "唑后"}, {"probability": {"variance": 0.003126, "average": 0.976276, "min": 0.810219}, "location": {"width": 148, "top": 947, "height": 17, "left": 421}, "words": "患者的血药浓度较年轻"}, {"probability": {"variance": 0.011753, "average": 0.924905, "min": 0.685235}, "location": {"width": 104, "top": 966, "height": 17, "left": 148}, "words": "此无需调整剂量"}, {"probability": {"variance": 0.09835, "average": 0.684424, "min": 0.370815}, "location": {"width": 90, "top": 946, "height": 30, "left": 953}, "words": "行"}, {"probability": {"variance": 8e-06, "average": 0.997527, "min": 0.991122}, "location": {"width": 104, "top": 995, "height": 21, "left": 160}, "words": "药物相互作用】"}, {"probability": {"variance": 5.1e-05, "average": 0.995143, "min": 0.972054}, "location": {"width": 232, "top": 1027, "height": 21, "left": 170}, "words": "除非特别注明,药物相互作用的研"}, {"probability": {"variance": 0.047992, "average": 0.74604, "min": 0.357237}, "location": {"width": 488, "top": 1011, "height": 50, "left": 524}, "words": "者中进行,采用多法注演真素"}, {"probability": {"variance": 0.019552, "average": 0.946951, "min": 0.377033}, "location": {"width": 370, "top": 1047, "height": 25, "left": 143}, "words": "稳态浓度。这些研究结果对于其他人群和其他给药径"}, {"probability": {"variance": 0.011401, "average": 0.95862, "min": 0.676124}, "location": {"width": 128, "top": 1079, "height": 22, "left": 196}, "words": "阐述了其他药物对"}, {"probability": {"variance": 0.009077, "average": 0.930924, "min": 0.736694}, "location": {"width": 98, "top": 1076, "height": 23, "left": 385}, "words": "唑的影响,伏"}, {"probability": {"variance": 0.00207, "average": 0.970327, "min": 0.891694}, "location": {"width": 57, "top": 1081, "height": 21, "left": 581}, "words": "物的影响"}, {"probability": {"variance": 0.003315, "average": 0.95327, "min": 0.855324}, "location": {"width": 65, "top": 1081, "height": 22, "left": 714}, "words": "的相互作"}, {"probability": {"variance": 0.020314, "average": 0.856263, "min": 0.713735}, "location": {"width": 19, "top": 1080, "height": 18, "left": 986}, "words": "按7"}, {"probability": {"variance": 0.012981, "average": 0.951635, "min": 0.578508}, "location": {"width": 178, "top": 1098, "height": 20, "left": 146}, "words": "列顺序阐述:禁止合用:合"}, {"probability": {"variance": 0.017972, "average": 0.924221, "min": 0.58304}, "location": {"width": 130, "top": 1101, "height": 18, "left": 400}, "words": "整剂量井进行密切"}, {"probability": {"variance": 0, "average": 0.996897, "min": 0.996897}, "location": {"width": 16, "top": 1099, "height": 20, "left": 875}, "words": "互"}, {"probability": {"variance": 0.007465, "average": 0.927224, "min": 0.805776}, "location": {"width": 45, "top": 1103, "height": 16, "left": 938}, "words": "但可能"}, {"probability": {"variance": 1e-06, "average": 0.999043, "min": 0.997726}, "location": {"width": 72, "top": 1121, "height": 16, "left": 141}, "words": "床治疗有益"}, {"probability": {"variance": 0.019067, "average": 0.929253, "min": 0.421049}, "location": {"width": 390, "top": 1138, "height": 45, "left": 138}, "words": "其他药对伏立康唑的影响丽珠制药厂"}, {"probability": {"variance": 0.039508, "average": 0.893514, "min": 0.410507}, "location": {"width": 171, "top": 1181, "height": 22, "left": 168}, "words": "伏立康唑通过胞色素P4"}, {"probability": {"variance": 0.00449, "average": 0.932833, "min": 0.865822}, "location": {"width": 32, "top": 1183, "height": 17, "left": 609}, "words": "和C"}, {"probability": {"variance": 0.022508, "average": 0.935233, "min": 0.37152}, "location": {"width": 297, "top": 1177, "height": 26, "left": 709}, "words": "些同工酶的抑制剂诱导剂可以分别增高或"}, {"probability": {"variance": 0.003967, "average": 0.974452, "min": 0.786283}, "location": {"width": 150, "top": 1202, "height": 18, "left": 139}, "words": "低伏立康唑的血药浓度"}, {"probability": {"variance": 0.007257, "average": 0.954995, "min": 0.57141}, "location": {"width": 560, "top": 1231, "height": 21, "left": 167}, "words": "利平(CYP450诱导剂):与利福平(每日一次,每次0.6g)合用,伏立康唑的Cn"}, {"probability": {"variance": 5.4e-05, "average": 0.990992, "min": 0.976956}, "location": {"width": 93, "top": 1233, "height": 18, "left": 808}, "words": "浓度)和AU"}, {"probability": {"variance": 0, "average": 0.988999, "min": 0.988999}, "location": {"width": 15, "top": 1235, "height": 17, "left": 955}, "words": "药"}, {"probability": {"variance": 0.003172, "average": 0.97749, "min": 0.724878}, "location": {"width": 522, "top": 1251, "height": 21, "left": 153}, "words": "时曲线下面积)分别降低93%和96%。因此禁止本品与利福平合用(参见【禁忌"}, {"probability": {"variance": 0.010266, "average": 0.95954, "min": 0.438219}, "location": {"width": 841, "top": 1285, "height": 22, "left": 167}, "words": "卡马西平和苯巴比妥(潜在的CYP450诱导剂):尽管未经研究,卡马西平和苯巴比妥可能会显著降低伏立唑的血药浓度,因"}, {"probability": {"variance": 0.008482, "average": 0.965047, "min": 0.609092}, "location": {"width": 296, "top": 1307, "height": 19, "left": 147}, "words": "禁止木品与这两种药物合用(参见【禁忌】)"}, {"probability": {"variance": 0.01887, "average": 0.928429, "min": 0.522378}, "location": {"width": 415, "top": 1338, "height": 21, "left": 167}, "words": "西米替工(非特异性的.CYP450抑制剂,并可增高胃酸的PH值"}, {"probability": {"variance": 0.008709, "average": 0.955667, "min": 0.672184}, "location": {"width": 306, "top": 1338, "height": 21, "left": 658}, "words": "丁(每日2次,每次0.4g)合用时,伏立康唑的"}, {"probability": {"variance": 0.003209, "average": 0.974687, "min": 0.749005}, "location": {"width": 316, "top": 1360, "height": 18, "left": 161}, "words": "UCt分别增高18%和23%。两者合用无需调整"}, {"probability": {"variance": 0.010257, "average": 0.962014, "min": 0.481125}, "location": {"width": 724, "top": 1390, "height": 23, "left": 161}, "words": "蓝尼替丁(增高胃酸PH值):雷尼替丁(每日二次,每次0.15g)对伏立康唑的Cmax和AUC无显著影响"}, {"probability": {"variance": 0.001999, "average": 0.981794, "min": 0.724063}, "location": {"width": 804, "top": 1424, "height": 20, "left": 162}, "words": "大环内酯类抗生素:红霉素(CYP3A4抑制剂,每日二次,每次1g)和阿奇霉素(每日一次,每次0.5g)对伏立康唑的"}, {"probability": {"variance": 0.012242, "average": 0.950531, "min": 0.620888}, "location": {"width": 137, "top": 1443, "height": 19, "left": 132}, "words": "和AUCt无显著影响"}, {"probability": {"variance": 2e-06, "average": 0.998568, "min": 0.995387}, "location": {"width": 184, "top": 1476, "height": 21, "left": 132}, "words": "伏立康唑对其他药物的影响"}, {"probability": {"variance": 0.007448, "average": 0.976036, "min": 0.387854}, "location": {"width": 818, "top": 1507, "height": 23, "left": 158}, "words": "伏立康唑抑制细胞色素P450同工酶的活性,包括CYP2C19,CYP2C9和CYP3A4因此本品可能会使那些通过CYP450同"}, {"probability": {"variance": 0.007576, "average": 0.953301, "min": 0.760493}, "location": {"width": 52, "top": 1597, "height": 21, "left": 449}, "words": "362-02"}], "language": 3}